Isolated nucleotide molecule and method of sensing and killing of pathogenic microorganism
The present invention relates to an isolated nucleic acid molecule comprising a first nucleotide sequence encoding a protein that detects the presence, amount or both of a pathogenic microorganism by forming a complex with a protein produced by said pathogenic microorganism; a second nucleotide sequence encoding an antimicrobial peptide, wherein the antimicrobial peptide is effective against the pathogenic microorganism detected by the protein encoded by the first nucleotide sequence, wherein the second nucleotide sequence is under control of a promoter that is induced by the complex of the protein encoded by the first nucleotide sequence and the protein produced by said pathogenic microorganism. A recombinant microorganism comprising the isolated nucleic acid molecule and a method of sensing and killing pathogenic microorganisms is also described.
1. An isolated nucleic acid molecule comprising:
a first nucleotide sequence encoding a protein that is able to form a complex with an acyl homoserine lactone (AHL) produced by a pathogenic microorganism; and
a second nucleotide sequence encoding an antimicrobial peptide, wherein the antimicrobial peptide is effective against the pathogenic microorganism, wherein the second nucleotide sequence is under control of a promoter that is induced by the complex of the protein encoded by the first nucleotide sequence and the acyl homoserine lactone (AHL) produced by said pathogenic microorganism, and wherein the protein encoded by the second nucleotide sequence is a bacterocin.
2. The isolated nucleotide acid molecule of claim 1 , wherein the nucleic acid molecule further comprises a third nucleotide sequence encoding a protein that is capable of lysing a cell hosting the isolated nucleic acid molecule, wherein said third nucleotide sequence is under control of a promoter that is induced by the complex of the protein encoded by the first nucleotide sequence and the acyl homoserine lactone (AHL) produced by said pathogenic microorganism.
3. The isolated nucleic acid molecule of claim 1 , wherein the first nucleotide sequence is under control of a constitutively active promoter.
4. The isolated nucleic acid molecule of claim 1 , wherein the protein encoded by the first nucleotide sequence is a transcription factor.
5. The isolated nucleic acid molecule of claim 1 , wherein the protein encoded by the first nucleotide sequence is the transcription factor LasR that binds to the AHL N-3-oxododecanoyl homoserine lactone (3OC 12 HSL).
6. The isolated nucleic acid molecule of claim 5 , wherein the inducible promoter of the second nucleotide sequence is a luxR promoter that is bound and induced by a complex of LasR and 3OC 12 HSL.
7. The isolated nucleic acid molecule of claim 1 , wherein the bacteriocin is a pyocin.
8. The isolated nucleic acid molecule of claim 7 , wherein the pyocin is pyocin S5.
9. The isolated nucleic acid molecule of claim 1 , wherein the protein encoded by the first nucleotide sequence, the protein encoded by the second nucleotide sequence or both are specific for a pathogenic microorganism.
10. The isolated nucleic acid molecule of claim 9 , wherein the pathogenic microorganism is selected from the group consisting of Pseudomonas aeruginosa, Clostridium difficile, Escherichia coli, Helicobacter pylori, Salmonella, Vibrio cholera and Yersinia.
11. The isolated nucleic acid molecule of claim 2 , wherein the protein encoded by the third nucleotide sequence is a lysis protein that lyses the cell membrane of an E. coli host cell.
12. The isolated nucleic acid molecule of claim 11 , wherein the protein encoded by the third nucleotide sequence is the E7 lysis protein.
13. The isolated nucleic acid molecule of claim 2 , wherein the inducible promoter of the second nucleotide sequence is a luxR promoter that is bound and induced by a complex of LasR and 3OC 12 HSL.
14. The isolated nucleic acid molecule of claim 1 , wherein the first nucleotide sequence has the nucleotide sequence set forth in SEQ ID NO:1.
15. The isolated nucleic acid molecule of claim 1 , wherein the second nucleotide sequence together with the inducible promoter has the nucleotide sequence set forth in SEQ ID NO:2.
16. The isolated nucleic acid molecule of claim 2 , wherein the third nucleotide sequence together with the inducible promoter has the nucleotide sequence set forth in SEQ ID NO:3.
17. The isolated nucleic acid molecule of claim 2 , wherein the isolated nucleic acid molecule comprises the nucleotide sequence set forth in SEQ ID NO:4.
18. The isolated nucleic acid molecule of claim 1 comprised in a vector.
19. A recombinant microorganism comprising the isolated nucleic acid molecule of claim 1 .
20. A recombinant microorganism comprising the isolated nucleic acid molecule of claim 18 .
21. The recombinant microorganism of claim 20 , wherein the microorganism is E. coli.
22. A method of sensing and inhibiting the growth of or killing pathogenic microorganisms, the method comprising contacting the recombinant microorganism of claim 19 with the pathogenic microorganism.
23. The method of claim 22 , wherein the method is a method of sensing and killing pathogenic microorganisms in a subject, the method comprising administering the recombinant microorganism of claim 19 to said subject.
24. The method of claim 22 , wherein the pathogenic microorganism is a human pathogen.
25. The method of claim 22 , wherein the pathogenic microorganism is selected from the group consisting of Pseudomonas aeruginosa, Clostridium difficile, Escherichia coli, Helicobacter pylori, Salmonella, Vibrio cholera and Yersinia.